Four mutations in Epidermodysplasia verruciformis 1 (EVER1) gene are not contributors to susceptibility in RRP

International Journal of Pediatric Otorhinolaryngology

Volumn 70, Issue 7, 2006, Pages 1235-1240

  Donfack, Joseph ^a   Buchinsky, Farrel J ^a   Derkay, Craig S ^b   Steinberg, Bettie M ^c   Choi, Sukgi S ^d   Conley, Stephen F ^e   Meyer III, Charles M ^f   McClay, John E ^g   Campisi, Paolo ^h   Hu, Fen Z ^a   Preston, Robert A ^a   Abramson, Allan L ^c   Ehrlich, Garth D ^a,i   Post, J Christopher ^a  

^a ALLEGHENY GENERAL HOSPITAL   (United States)

^b CHILDREN S HOSPITAL OF THE KING S DAUGHTERS   (United States)

^c LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^d CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^e Children's Hospital of Wisconsin   (United States)

^f CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^g CHILDREN S MEDICAL CENTER   (United States)

^h HOSPITAL FOR SICK CHILDREN   (Canada)

ⁱ DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Allele specific PCR; Epidermodysplasia verruciformis 1; Human papillomavirus; Mutation; Recurrent respiratory papillomatosis; Restriction fragment length polymorphism; TMC6

Indexed keywords

ALLELE; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; EPIDERMODYSPLASIA VERRUCIFORMIS; EVER 1 GENE; FEMALE; GEL ELECTROPHORESIS; GENE; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PAPILLOMATOSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE;

FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MEMBRANE PROTEINS; NEOPLASM RECURRENCE, LOCAL; PAPILLOMA; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PHENOTYPE; POINT MUTATION; RESPIRATORY TRACT NEOPLASMS; SEVERITY OF ILLNESS INDEX;

EID: 33747205452     PISSN: 01655876     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijporl.2006.01.001     Document Type: Article

References (21)

1. Buchinsky F., Derkay C., Leal S., Donfack J., Ehrlich G., and Post J. Multicenter initiative seeking critical genes in respiratory papillomatosis. Laryngoscope 114 2 (2004) 349-357
2. Wiatrak B., Wiatrak D., Broker T., and Lewis L. Recurrent respiratory papillomatosis: a longitudinal study comparing severity associated with human papilloma viral types 6 and 11 and other risk factors in a large pediatric population. Laryngoscope 114 (2004) 1-23
3. Rabah R., Lancaster W., Thomas R., and Gregoire L. Human papillomavirus-11-associated recurrent respiratory papillomatosis is more aggressive than human papillomavirus-6-associated disease. Pediatr. Dev. Pinhol. 4 (2001) 68-72
4. Orth G. Epidermodysplasia verruciformis. In: Salzman N.P., and Howley P.M. (Eds). The Papillomaviruses. The Papovaviridae 2 (1987), Plenum Press, New York, NY 199-243
5. Ramoz N., Rueda L., Bouadjar B., Favre M., and Orth G. A susceptibility locus for epidermodysplasia verruciformis, an abnormal predisposition to infection with the oncogenic human papillomavirus type 5, maps to chromosome 17qter in a region containing a psoriasis locus. J. Invest. Dermatol. 112 3 (1999) 259-263
6. Ramoz N., Taieb A., Rueda L., et al. Evidence for a nonallelic heterogeneity of epidermodysplasia verruciformis with two susceptibility loci mapped to chromosome regions 2p21-p24 and 17q25. J. Invest. Dermatol. 114 6 (2000) 1148-1153
7. Ramoz N., Rueda L., Bouadjar B., Montoya L., Orth G., and Favre M. Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis. Nat. Genet. 32 4 (2002) 579-581
8. Tate G., Suzuki T., Kishimoto K., and Mitsuya T. Novel mutations of EVER1/TMC6 gene in a Japanese patient with epidermodysplasia verruciformis. J. Hum. Genet. 49 4 (2004) 223-225
9. Bottema C., Sarkar G., Cassady J., Ii S., Dutton C., and Sommer S. Polymerase chain reaction amplification of specific alleles: a general method of detection of mutations, polymorphisms, and haplotypes. Methods Enzymol. 218 (1993) 388-402
10. Jablonska S., and Majewski S. Epidermodysplasia verruciforms: immunological and clinical aspects. Curr. Top. Microbiol. Immunol. 186 (1994) 157-175
11. Lane J., Bowman P., and Cohen D. Epidermodysplasia verruciformis. S. Med. J. 96 (2003) 613-615
12. Penaloza-Plascencia M., Montoya-Fuentes H., Flores-Martinez S., Fierro-Velasco F., and Sanchez-Corona J. Molecular identification of 7 human papillomavirus types in recurrent respiratory papillomatosis. Arch. Otolaryngol. Head Neck Surg. 126 (2000) 1119-1123
13. Major T., Szarka K., Sziklai I., Gergely L., and Czegledy J. The characteristics of human papillomavirus DNA in head and neck cancers and papillomas. J. Clin. Pathol. 58 (2005) 51-55
14. Hanley J., and Lippman-Hand A. If nothing goes wrong, is everything alright?. JAMA 249 (1983) 1743-1745
15. Bergmann C., Senderek J., Kupper F., et al. PKHD1 mutations in autosomal recessive polycystic kidney disease (ARPKD). Hum. Mutat. 23 (2004) 453-463
16. Onuchic L., Furu L., Nagasawa Y., et al. PKHD1, the polycystic kidney and hepatic disease 1 gene, encodes a novel large protein containing multiple immunoglobulin-like plexin-transcription-factor domains and parallel beta-helix 1 repeats. Am. J. Hum. Genet. 70 (2002) 1305-1317
17. Ward C., Hogan M., Rossetti S., et al. The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein. Nat. Genet. 30 (2002) 259-269
18. Furu L., Onuchic L., Gharavi A., et al. Milder presentation of recessive polycystic kidney disease requires presence of amino acid substitution mutations. J. Am. Soc. Nephrol. 14 (2003) 2004-2014
19. Rossetti S., Torra R., Coto E., et al. A complete mutation screen of PKHD1 in autosomal-recessive polycystic kidney disease (ARPKD) pedigrees. Kidney Int. 64 (2003) 391-403
20. Bergmann C., Senderek J., Sedlacek B., et al. Spectrum of mutations in the gene for autosomal recessive polycystic kidney disease (ARPKD/PKHD1). J. Am. Soc. Nephrol. 13 (2003) 76-89
21. Bergmann C., Senderek J., Schneider F., et al. PKHD1 mutations in families requesting prenatal diagnosis for autosomal recessive polycystic kidney disease (ARPKD). Hum. Mutat. 23 (2004) 487-495